Posts

IP implications of the FDA guidance for use of AI in drug development

[Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents

When "mayo" is not mayonnaise, yet still is mayonnnaise: All a matter of the label?

Allergan v Sandoz: when obvious is not obvious enough!